- Citado por Google
- Similares en SciELO
- Similares en Google
Revista chilena de cirugía
versión On-line ISSN 0718-4026
CASTILLO C, OCTAVIO et al. Laparoscopic radical nephrectomy: Our experience in 150 consecutives patients. Rev Chil Cir [online]. 2008, vol.60, n.4, pp.297-302. ISSN 0718-4026. http://dx.doi.org/10.4067/S0718-40262008000400006.
Introduction: Surgery remains the only treatment with chance of cure in renal carcinoma. Laparoscopic radical nephrectomy (L-RN) is the surgical gold Standard. A series of 150 patients treated with L-RN is presented. Material y Methods: 150 patients were treated with L-RN between February 1994 and August 2006. Data was prospectively collected and present analysis included age, gender, surgical indication, operative time, blood loss, perioperative complications, conversión rate. Final pathology and follow-up were also registered. Results: Median age of the series was 60 years (range 18-86 y.), male/female ratio 2:1. Surgical indications included Wilms tumor in 137 cases, complex cystic lesions in 5 cases and Angyomyo-lipoma in 1 case. Laparoscopic hand assisted technique was used in 83 cases (58%) and puré laparoscopy en 60 cases (42%). Median operative time was 107 minutes (range 40-240 m.). Median blood loss was 160 ce (range 0-2000 ce). There were intraoperative complications in 5 patients (3.5%) 9 patients presented with postoperatory complications (6.3%). Final pathology reported renal carcinoma pT1-T3c in 135 patients, Oncocytoma in 2, Angyomyolipoma in 2 patients, Transicional cell carcinoma in 1 patient, Mixoliposarcoma in 1 patient, lung tumor metastases de tumor 1 patient y inflammatory Pseudotumor in 1 case. Surgical margins were reported negative in all cases. Median oncologic follow-up time was 33 months (1-138 m.). Conclusions: Laparoscopic radical nephrectomy has the same oncological results, like open surgery, whit all the advantages of laparoscopic surgery. To day is the gold standard in TNM T1, T2 and for a few T3
Palabras clave : Nephrectomy; laparoscopic; renal cancer.